Abstract 1309: Identification of aurora kinase a as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors

Chun‐Nan Yeh(Chang Gung University), Jonathan A. Fletcher(Harvard University), Yung‐Chan Lin(Taipei Veterans General Hospital), Shih‐Chiang Huang(Linkou Chang Gung Memorial Hospital), Chi‐Tung Cheng(Chang Gung Memorial Hospital), Ta‐Chung Chao(National Yang Ming Chiao Tung University), Ting‐Wei Chang(Kaohsiung Medical University), Jen‐Shi Chen(Linkou Chang Gung Memorial Hospital), Kun‐Chun Chiang(Chang Gung University), Yao-Shan Wen(Taipei Veterans General Hospital), Ta‐Sen Yeh(Chang Gung Memorial Hospital), Fangyi Yao(Nanchang University), Yeng-Yang Chen(Kaohsiung Chang Gung Memorial Hospital), Cheng‐Hwai Tzeng(Taipei Veterans General Hospital), Chueh‐Chuan Yen(Taipei Veterans General Hospital)
Cancer Research
October 1, 2014
10.1158/1538-7445.am2014-1309
Cited by 0

Related Papers

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|1k
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
|Oncogene|2001|700
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2000|647